GLOW (70mg) Lyophilised research material

GLOW 70 mg (Lyophilised Research Peptide Blend)

GLOW 70 mg is a freeze-dried (lyophilised) multi-peptide research compound supplied strictly for laboratory research use only. It is not a medicine, supplement, or approved therapeutic product.

Composition

Each 70 mg vial typically contains a fixed blend of:

• 50 mg GHK-Cu (copper-binding tripeptide)
• 10 mg BPC-157 (synthetic gastric pentadecapeptide fragment)
• 10 mg TB-500 / Thymosin Beta-4 fragment

Total = 70 mg combined peptide content

Physical form

• Lyophilised (freeze-dried) powder
• Sterile vial sealed for laboratory stability
• Requires reconstitution (in research settings only) before analytical use

Stated research purpose

GLOW 70 mg is used in in-vitro or controlled laboratory research to study:

• Tissue repair signalling pathways
• Collagen and extracellular matrix activity
• Angiogenesis and cell migration models
• Multi-peptide interaction (synergy studies)
• Dermal / regenerative biology pathways

Regulatory status

• Not a licensed medicine
• Not approved for human or veterinary use
• Supplied only as a research chemical / reference material

Manufacturers explicitly label it:

“For laboratory research use only. Not for human consumption or injection.”